79 related articles for article (PubMed ID: 1986559)
1. Nodular regenerative hyperplasia: a cause of ascites and hepatomegaly after chemotherapy for leukemia.
Rosen AA; Iseri O; Fishbein G; Knodell RG
Am J Gastroenterol; 1991 Jan; 86(1):86-8. PubMed ID: 1986559
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for acute myeloid leukemias with cytosine arabinoside, daunorubicin, etoposide, and mitoxantrone may cause permanent oligoasthenozoospermia or amenorrhea in middle-aged patients.
Lemez P; Urbánek V
Neoplasma; 2005; 52(5):398-401. PubMed ID: 16151584
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside].
Patterson D; Kravtsova VM; Petrova EM; Zabelina TS; Balaian LN
Ter Arkh; 1987; 59(12):81-6. PubMed ID: 3482131
[TBL] [Abstract][Full Text] [Related]
4. Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine.
Gerrard G; Payne E; Baker RJ; Jones DT; Potter M; Prentice HG; Ethell M; McCullough H; Burgess M; Mehta AB; Ganeshaguru K
Haematologica; 2004 Jul; 89(7):782-90. PubMed ID: 15257929
[TBL] [Abstract][Full Text] [Related]
5. A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. The KRN8602 Leukemia Study Group.
Takemoto Y; Sampi K; Kuraishi Y; Okabe K; Tamura K; Mizoguchi H; Saito H; Masaoka T; Ogawa M
Int J Hematol; 1999 Jul; 70(1):20-5. PubMed ID: 10446490
[TBL] [Abstract][Full Text] [Related]
6. Intensive short-term chemotherapy for patients with acute myelogenous leukemia: long-term follow-up.
Oblon DJ; Weiner RS; Kramer BS; Ross W; Noyes WD; Boyett J; Kitchens CS
Cancer Treat Rep; 1985 Dec; 69(12):1425-7. PubMed ID: 2416439
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy for acute myelogenous leukemia.
Kalaycio M
Curr Hematol Rep; 2005 Jan; 4(1):49-50. PubMed ID: 15610659
[No Abstract] [Full Text] [Related]
8. Cerebellar toxicity with medium-dose cytarabine in a young patient with renal insufficiency.
Chim CS; Kwong YL
Am J Hematol; 1996 Nov; 53(3):208. PubMed ID: 8895701
[No Abstract] [Full Text] [Related]
9. A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia.
Vogler WR; Velez-Garcia E; Omura G; Raney M
Semin Oncol; 1989 Feb; 16(1 Suppl 2):21-4. PubMed ID: 2648581
[No Abstract] [Full Text] [Related]
10. [Poor response in patients with de novo acute myeloid leukemia and erythroblastic or megakaryocytic dysplasia to treatment with standard doses of cytosine arabinoside and daunorubicin].
Lemez P; Gáliková J; Haas T
Vnitr Lek; 1999 Jun; 45(6):342-6. PubMed ID: 11045169
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein (Pgp) modulation in untreated acute myeloid leukemia (AML): Cancer and Leukemia Group B (CALGB) trials in younger and older adults.
Kolitz JE; George SL; Baer MR; Lee EJ; Bloomfield CD; Larson RA;
Ann Hematol; 2004; 83 Suppl 1():S103-4. PubMed ID: 15124695
[No Abstract] [Full Text] [Related]
12. Modeling of in vitro drug activity and prediction of clinical outcome in acute myeloid leukemia.
Quartino A; Karlsson MO; Freijs A; Jonsson N; Nygren P; Kristensen J; Lindhagen E; Larsson R
J Clin Pharmacol; 2007 Aug; 47(8):1014-21. PubMed ID: 17660484
[TBL] [Abstract][Full Text] [Related]
13. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia.
Novitzky N; Thomas V; Abrahams L; du Toit C; McDonald A
Am J Hematol; 2004 Aug; 76(4):319-29. PubMed ID: 15282663
[TBL] [Abstract][Full Text] [Related]
14. [Results of induction therapy in newly diagnosed acute myeloid leukemias in study 911 at the Institute of Hematology and Blood Transfusion].
Lemez P; Vítek A; Jelínek J; Lukásová M; Palecek A; Sajdová J; Jedlicková A; Vorlová Z
Vnitr Lek; 1995 Jan; 41(1):34-9. PubMed ID: 7716891
[TBL] [Abstract][Full Text] [Related]
15. Results of liver transplantation for nodular regenerative hyperplasia.
Radomski JS; Chojnacki KA; Moritz MJ; Rubin R; Armenti VT; Wilson GA; Herrine S; Conn M
Am Surg; 2000 Nov; 66(11):1067-70. PubMed ID: 11090022
[TBL] [Abstract][Full Text] [Related]
16. Acyclovir bioavailability in patients with acute myelogenous leukemia treated with daunorubicin and cytarabine.
Sitar DS; Aoki FY; Bow EJ
J Clin Pharmacol; 2008 Aug; 48(8):995-8. PubMed ID: 18495946
[No Abstract] [Full Text] [Related]
17. [The use of intermediate dose cytosine arabinoside (ID Ara-C) in the treatment of relapsing or refractory cases of acute myelogenous leukemia].
Kawano F; Tejima Y; Tajima H; Lee SY; Shiozaki A; Nakai R; Chyosa M; Sawada T; Maeda Y; Mizokuni T
Rinsho Ketsueki; 1986 Mar; 27(3):315-20. PubMed ID: 3461178
[No Abstract] [Full Text] [Related]
18. Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients.
de Boer NK; Zondervan PE; Gilissen LP; den Hartog G; Westerveld BD; Derijks LJ; Bloemena E; Engels LG; van Bodegraven AA; Mulder CJ
Dig Liver Dis; 2008 Feb; 40(2):108-13. PubMed ID: 18083079
[TBL] [Abstract][Full Text] [Related]
19. No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group.
Miyawaki S; Tanimoto M; Kobayashi T; Minami S; Tamura J; Omoto E; Kuriyama K; Hatake K; Saito K; Kanamaru A; Oh H; Ohtake S; Asou N; Sakamaki H; Yamada O; Jinnai I; Tsubaki K; Takeyama K; Hiraoka A; Matsuda S; Takahashi M; Shimazaki C; Adachi K; Kageyama S; Ohno R
Int J Hematol; 1999 Aug; 70(2):97-104. PubMed ID: 10497848
[TBL] [Abstract][Full Text] [Related]
20. Three cases of nodular regenerative hyperplasia of the liver following renal transplantation.
Buffet C; Cantarovitch M; Pelletier G; Fabre M; Martin E; Charpentier B; Etienne JP; Fries D
Nephrol Dial Transplant; 1988; 3(3):327-30. PubMed ID: 3140108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
